Abstract
Management of Anderson-Fabry disease (AFD) is contentious, particularly regarding enzyme replacement therapy (ERT). We report results of a Delphi consensus panel on AFD management.
Original language | English |
---|---|
Pages (from-to) | 751-756 |
Number of pages | 6 |
Journal | European Journal of Internal Medicine |
Volume | 25 |
DOIs | |
Publication status | Published - 2014 |
Keywords
- Diagnosis
- Fabry disease
- Management
- Treatment